12:00 AM
Jul 30, 2012
 |  BC Week In Review  |  Company News  |  Deals

Arena, Suzhou Connect Biopharmaceuticals deal

Chinese company Suzhou Connect said it received an exclusive, worldwide license from Arena to develop and commercialize preclinical small...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >